Growing community of inventors

Dublin, Ireland

John Climax

Average Co-Inventor Count = 2.93

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 67

John ClimaxDavid Coughlan (19 patents)John ClimaxMehar Manku (15 patents)John ClimaxJames Dunne (5 patents)John ClimaxJonathan Rowe (3 patents)John ClimaxKevin Duffy (2 patents)John ClimaxMoayed Hamza (1 patent)John ClimaxMarkus Weissbach (1 patent)John ClimaxKevin Duffy (0 patent)John ClimaxKevin Duffy (0 patent)John ClimaxJohn Climax (22 patents)David CoughlanDavid Coughlan (22 patents)Mehar MankuMehar Manku (107 patents)James DunneJames Dunne (5 patents)Jonathan RoweJonathan Rowe (8 patents)Kevin DuffyKevin Duffy (2 patents)Moayed HamzaMoayed Hamza (1 patent)Markus WeissbachMarkus Weissbach (1 patent)Kevin DuffyKevin Duffy (0 patent)Kevin DuffyKevin Duffy (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ds Biopharma Limited (8 from 13 patents)

2. Afimmune Limited (7 from 7 patents)

3. Dignity Sciences Limited (6 from 12 patents)

4. Dignity Sciences Limted (1 from 1 patent)


22 patents:

1. 12274685 - Compositions comprising 15-HEPE and methods of using the same

2. 12076304 - Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseases

3. 12017986 - Compositions comprising oxo-derivatives of fatty acids and methods of making and using same

4. 11478442 - Pharmaceutical compositions comprising DGLA and use of same

5. 10849870 - Pharmaceutical compositions comprising DGLA and use of same

6. 10813903 - Compositions comprising 15-HEPE and methods of using the same

7. 10716773 - Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease

8. 10570083 - Compositions comprising oxo-derivatives of fatty acids and methods of making and using same

9. 10537543 - Pharmaceutical compositions comprising DGLA and use of same

10. 10363235 - Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same

11. 10231945 - Compositions comprising 15-HEPE and methods of using the same

12. 10105333 - Pharmaceutical compositions comprising DGLA and use of same

13. 10047033 - Compositions comprising oxo-derivatives of fatty acids and methods of making and using same

14. 9855238 - Compositions comprising 15-HEPE and methods of using the same

15. 9855236 - Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…